Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/1580ebd3-ae75-4975-8a7a-9ddfbbd9f7e5/

PTX

Prescient Therapeutics Limited
Chart
0.09 AUD
Latest Week 2026-07-24
HealthcareBiotechnologyMICRO
Snapshot 2026-07-26 · 0.7w · Fresh
0.63
OS Score
58.0%
Value
57.0%
Quality
58.0%
Momentum
1/9
F-Score
0.575
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
58.0%ile
P/B
8.5×
FCF Yield
-0.081
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
41.00000000
/100 — 1=cheapest
VC2 (Trending Value)
41.00000000
/100
VC3 (Buyback)
41.00000000
/100
Negative FCF yield (-8.1%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
57.0%ile
ROE
-0.643
ROA
-0.503
Current
4.08
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
5yr Consist
No
F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
58.0%ile
6M Return
9.5%
12M Return
104.4%
12-1 Mom
35.6%
Risk-Adj
0.47
Vol 252d
75.5%
Vol 60d
181.9%
↑ Expanding
Max DD 12M
-44.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 36% is very strong — a clear uptrend. Near-term vol (182%) is expanding vs long-term (76%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.63
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 145 peers
Sector Value %ile
66.4%
Sector Quality %ile
63.7%
P/B z-score
0.10
Sector Avg OS
42.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 97.0% 89.0%
SDI SDI Limited 96.0% 86.0% 88.0% 96.0%
AGN Argenica Therapeutics Limited 93.0% 82.0% 80.0% 81.0%
BP8 BPH Global Ltd 93.0% 81.0% 80.0% 81.0%
PCK PainChek Limited 89.0% 78.0% 76.0% 77.0%
TRI TrivarX Limited 87.0% 76.0% 75.0% 76.0%
AVH AVITA Medical, Inc. 85.0% 75.0% 73.0% 74.0%
CUV Clinuvel Pharmaceuticals Limited 85.0% 93.0% 98.0% 12.0%
Factor Interactions
Volatility Expanding
60-day vol (182%) significantly exceeds 252-day (76%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
3.7% avg (3 factors)
Quality
D
33.3% avg (3 factors)
Momentum
B
66.7% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.630—0—
Value %ile0.580—0—
Quality %ile0.570—0—
Momentum %ile0.580—0—
F-Score1.000—8—
Confidence0.258—8—
Volatility0.755—8—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
8.50
FCF Yield
-8.1%
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-64.3%
Return on Assets
-50.3%
Current Ratio
4.08
MomentumPrice trend strength over different horizons
6M Return
9.5%
12M Return
104.4%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
35.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.47
Growth & StabilityEarnings trajectory, consistency, and capital allocation
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
1
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
41
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
41
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
41
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity